DECEMBER 2025 EXTRA - ALERT
Past Editions—Need to Know Archives
As a retailer, you have a direct stake in clear, consistent supplement labeling because ambiguity drives supply-chain friction, compliance costs, and consumer hesitation at the shelf. In addition, if you have store branded supplements, you may be even more directly impacted by class action litigation citing placement of the DSHEA disclaimer as a potential violation of DSHEA and consumer protection laws.
Today’s FDA announcement is a welcome step to avoiding unnecessary litigation and preventing consumer confusion.
FDA’s clarification on DSHEA disclaimer placement reduces litigation risk for the brands you carry and helps stabilize labeling practices that have guided the marketplace for decades. This decision ultimately protects our retail partners by supporting continuity, reducing legal uncertainty, and strengthening consumer confidence.
See CRN’s statement in response to FDA’s announcement of enforcement discretion regarding the placement of the DSHEA disclaimer.
